These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 26391145)

  • 1. Should β-blockers be used in patients with heart failure and atrial fibrillation?
    Mareev Y; Cleland JG
    Clin Ther; 2015 Oct; 37(10):2215-24. PubMed ID: 26391145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.
    Kotecha D; Holmes J; Krum H; Altman DG; Manzano L; Cleland JG; Lip GY; Coats AJ; Andersson B; Kirchhof P; von Lueder TG; Wedel H; Rosano G; Shibata MC; Rigby A; Flather MD;
    Lancet; 2014 Dec; 384(9961):2235-43. PubMed ID: 25193873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Betablockers in patients with heart failure and atrial fibrillation].
    Pellicori P; Costanzo P
    G Ital Cardiol (Rome); 2015 Nov; 16(11):613-6. PubMed ID: 26571474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis.
    Rienstra M; Damman K; Mulder BA; Van Gelder IC; McMurray JJ; Van Veldhuisen DJ
    JACC Heart Fail; 2013 Feb; 1(1):21-8. PubMed ID: 24621795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy.
    Cadrin-Tourigny J; Shohoudi A; Roy D; Talajic M; Tadros R; Mondésert B; Dyrda K; Rivard L; Andrade JG; Macle L; Guerra PG; Thibault B; Dubuc M; Khairy P
    JACC Heart Fail; 2017 Feb; 5(2):99-106. PubMed ID: 28089316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of beta-blocker therapy in heart failure and atrial fibrillation.
    Fung JW; Yu CM; Kum LC; Yip GW; Sanderson JE
    Card Electrophysiol Rev; 2003 Sep; 7(3):236-42. PubMed ID: 14739721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redefining β-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: a machine learning cluster analysis.
    Karwath A; Bunting KV; Gill SK; Tica O; Pendleton S; Aziz F; Barsky AD; Chernbumroong S; Duan J; Mobley AR; Cardoso VR; Slater K; Williams JA; Bruce EJ; Wang X; Flather MD; Coats AJS; Gkoutos GV; Kotecha D;
    Lancet; 2021 Oct; 398(10309):1427-1435. PubMed ID: 34474011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry.
    Li SJ; Sartipy U; Lund LH; Dahlström U; Adiels M; Petzold M; Fu M
    Circ Heart Fail; 2015 Sep; 8(5):871-9. PubMed ID: 26243796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Blockers on Discharge From Acute Atrial Fibrillation Are Associated With Decreased Mortality and Lower Cerebrovascular Accidents in Patients With Heart Failure and Reduced Ejection Fraction.
    Abi Khalil C; Zubaid M; Asaad N; Rashed WA; Hamad AK; Singh R; Al Suwaidi J
    Angiology; 2018 Apr; 69(4):316-322. PubMed ID: 28737070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of beta-blockers in atrial fibrillation.
    Kühlkamp V; Bosch R; Mewis C; Seipel L
    Am J Cardiovasc Drugs; 2002; 2(1):37-42. PubMed ID: 14727997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate control in atrial fibrillation: choice of treatment and assessment of efficacy.
    Boriani G; Biffi M; Diemberger I; Martignani C; Branzi A
    Drugs; 2003; 63(14):1489-509. PubMed ID: 12834366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bucindolol hydrochloride in atrial fibrillation and concomitant heart failure.
    Black-Maier E; Steinberg BA; Piccini JP
    Expert Rev Cardiovasc Ther; 2015 Jun; 13(6):627-36. PubMed ID: 25959096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure.
    Kotecha D; Flather MD; Altman DG; Holmes J; Rosano G; Wikstrand J; Packer M; Coats AJS; Manzano L; Böhm M; van Veldhuisen DJ; Andersson B; Wedel H; von Lueder TG; Rigby AS; Hjalmarson Å; Kjekshus J; Cleland JGF;
    J Am Coll Cardiol; 2017 Jun; 69(24):2885-2896. PubMed ID: 28467883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockers treatment in heart failure with atrial fibrillation--Who should we believe?
    Chen Y; Huang W; Huang Y; Hu Y
    Int J Cardiol; 2016 Jan; 203():60-1. PubMed ID: 26492311
    [No Abstract]   [Full Text] [Related]  

  • 15. [Heart rate and outcome in patients with acute and chronic heart failure].
    Oliva F; Ammirati E; Campana C; Carubelli V; Cirò A; Di Tano G; Mortara A; Senni M; Morandi F; Metra M
    G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 1):3S-16. PubMed ID: 27030005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation-a meta-analysis.
    Xu T; Huang Y; Zhou H; Bai Y; Huang X; Hu Y; Xu D; Zhang Y; Zhang J
    BMC Cardiovasc Disord; 2019 Jun; 19(1):135. PubMed ID: 31159740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation and congestive heart failure.
    Roy D; Talajic M; Dubuc M; Thibault B; Guerra P; Macle L; Khairy P
    Curr Opin Cardiol; 2009 Jan; 24(1):29-34. PubMed ID: 19102036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials.
    Cleland JGF; Bunting KV; Flather MD; Altman DG; Holmes J; Coats AJS; Manzano L; McMurray JJV; Ruschitzka F; van Veldhuisen DJ; von Lueder TG; Böhm M; Andersson B; Kjekshus J; Packer M; Rigby AS; Rosano G; Wedel H; Hjalmarson Å; Wikstrand J; Kotecha D;
    Eur Heart J; 2018 Jan; 39(1):26-35. PubMed ID: 29040525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.
    Swedberg K; Olsson LG; Charlesworth A; Cleland J; Hanrath P; Komajda M; Metra M; Torp-Pedersen C; Poole-Wilson P
    Eur Heart J; 2005 Jul; 26(13):1303-8. PubMed ID: 15767288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does atrial fibrillation in elderly patients with chronic heart failure limit the efficacy of carvedilol? Suggestions from an observational study.
    Opasich C; De Feo S; Cioffi G; Pulignano G; Del Sindaco D; Tarantini L; Gualco A; Patrignani A
    Ital Heart J; 2005 Apr; 6(4):323-7. PubMed ID: 15902931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.